Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject

• Status: Completed
• Trial end date: 2014-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

This clinical trial was evaluated to compare the safety and pharmacokinetics of Besylsartan with Amosartan, which was available commercially after single oral dose in healthy male subjects.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Huons Co., Ltd.; Huons Co.,Ltd.
• Treatments: Losartan

Criteria

Inclusion Criteria:

• Body Mass Index (BMI) between 18 and 30

• Healthy as determined by a responsible physician

Exclusion Criteria:

• History of clinically significant disease

• Any chronic disease

• Creatine clearance less than 50ml/min

• Hypotension (100mmHg/60mmHg)

• Treatment of barbital type drug within 1 month

• Administration of herbal medicine within 7 days